Sanofi Consumer Healthcare India Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sanofi Consumer Healthcare India Ltd. on BSE

Load latest

Sanofi Consumer Healthcare India Ltd.

29 Jul 2025

4748.90

0.60%

Board Meeting

Sanofi Consumer Healthcare India Ltd - 544250 - Board Meeting Intimation for Consideration And Approval Of …

BSE India

Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and half year ended 30th June 2025

pdf

Sanofi Consumer Healthcare India Ltd.

14 Jul 2025

4748.90

0.60%

Company Update

Sanofi Consumer Healthcare India Ltd - 544250 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) …

BSE India

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended 30th June 2025

pdf

Sanofi Consumer Healthcare India Ltd.

26 Jun 2025

4748.90

0.60%

SAST

Sanofi Consumer Healthcare India Ltd - 544250 - Closure of Trading Window

BSE India

Intimation for Closure of Trading Window

pdf

Sanofi Consumer Healthcare India Ltd.

13 Jun 2025

4748.90

0.60%

Company Update

Sanofi Consumer Healthcare India Ltd - 544250 - Disclosure Under Securities And Exchange Board Of India …

BSE India

Please find enclosed the disclosure received from Opal Bidco SAS, in relation to acquisition of equity shares of the Company pursuant to Open Offer under SEBI (SAST) Regulations, 2011

pdf

Sanofi Consumer Healthcare India Ltd.

13 Jun 2025

4748.90

0.60%

SAST

Sanofi Consumer Healthcare India Ltd - 544250 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Opal Bidco SAS

pdf

Sanofi Consumer Healthcare India Ltd.

24 May 2025

4748.90

0.60%

Company Update

Sanofi Consumer Healthcare India Ltd - 544250 - Post-Offer Advertisement

BSE India

Citigroup Global Markets India Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Post-Offer Advertisement under Regulation 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the attention of the Shareholders of Sanofi Consumer Healthcare India Ltd ("Target Company").

pdf

Sanofi Consumer Healthcare India Ltd.

10 May 2025

4748.90

0.60%

Company Update

Sanofi Consumer Healthcare India Ltd - 544250 - Updates on Open Offer

BSE India

Citigroup Global Markets India Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on May 09, 2025.

pdf